Synthesis and anticancer activities of 6-amino amonafide derivatives

  title={Synthesis and anticancer activities of 6-amino amonafide derivatives},
  author={John T Norton and Mark A. Witschi and L. Luong and A. Kawamura and S. Ghosh and M. Sharon Stack and E. Sim and M. Avram and D. Appella and S. Huang},
  journal={Anti-Cancer Drugs},
  • John T Norton, Mark A. Witschi, +7 authors S. Huang
  • Published 2008
  • Chemistry, Medicine
  • Anti-Cancer Drugs
  • Amonafide is a DNA intercalator and topoisomerase II inhibitor in clinical development for the treatment of neoplastic diseases. Amonafide contains a free arylamine, which causes it to be metabolized in humans by N-acetyl transferase-2 (NAT2) into a toxic form. To eliminate the NAT2 acetylation of amonafide while retaining the anticancer properties, we have synthesized nine derivatives that are structurally similar to amonafide that should not be acetylated. Eight derivatives have arylamines at… CONTINUE READING
    38 Citations
    Synthesis, cytotoxicity, DNA binding and topoisomerase II inhibition of cassiarin A derivatives.
    • 9
    Is an Efficacious and Minimally Toxic Amonafide Derivative in Murine Models of Human Cancer 1
    Synthesis and evaluation of novel amonafide–polyamine conjugates as anticancer agents
    • 5
    Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.
    • 15
    • PDF
    Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
    • 26


    Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
    • 89
    • PDF
    Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
    • 34
    Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
    • 89
    Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
    • M. Costanza, D. Berry, +7 authors A. Lyss
    • Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 1995
    • 41
    • PDF
    ATP-bound Topoisomerase II as a Target for Antitumor Drugs*
    • 53
    • PDF